Affiliation:
1. Haut‐ und Venenzentrum Mainz Dr. med. Uwe Kirschner and Colleagues Mainz Germany
2. Temedica GmbH Munich Germany
3. Novartis Pharma GmbH Nuremberg Germany
4. Haut‐ und Laserzentrum Freising Prof. Dr. med. Hjalmar Kurzen Freising Germany
5. Technical University of Munich Munich Germany
Abstract
SUMMARYBackgroundThe chronic inflammatory skin disease hidradenitis suppurativa (HS) leads to severe pain and reduced quality of life. Nonetheless, it often takes years until a correct diagnosis is made. In this analysis, disease‐related experiences and pathways of patients with HS were investigated and compared with the physicians’ perspective.MethodsPublic posts on forums and social media as well as results of a survey conducted among dermatologists and their patients on the actual medical care reality of HS in Germany were analysed. Furthermore, claims data from German health insurance companies were evaluated.ResultsPatients with HS suffer from a 43.3% reduction in working ability. Dermatology (26.5%) was the most frequently consulted specialty, with HS diagnosed predominantly in the inpatient setting (43.8%). Abscesses were described as the most frequent alternative diagnosis in HS patients (53.2%). Patient‐reported changes of physicians in dermatology (34.1%) and surgery (42.4%) occurred predominantly within the specialty. Dermatology received most referrals from general practitioners (67.1%), but only 12.1% from surgeons.ConclusionThere is an urgent need to reduce the delay in diagnosis and the prolonged burden of disease in patients with HS. Therefore, awareness of the disease, its detection and treatment which goes beyond dermatology should be promoted, if possible as part of medical studies.